Peroxisomal disorders in neurology

Journal of the Neurological Sciences

Volumn 88, Issue 1-3, 1988, Pages 1-39

  Wanders, R J A ^a   Heymans, H S A ^a   Schutgens, R B H ^a   Barth, P G ^a   van den Bosch, H ^b   Tager, J M ^c  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Adrenoleukodystrophy; Fatty acid; Inborn error; Peroxisomal disorder; Peroxisome; Zellweger syndrome

Indexed keywords

ADRENOLEUKODYSTROPHY; HUMAN; PEROXISOME; PRIORITY JOURNAL; REFSUM DISEASE; REVIEW; ZELLWEGER SYNDROME;

ANIMAL; MICROBODIES; NERVOUS SYSTEM DISEASES; SUPPORT, NON-U.S. GOV'T; ZELLWEGER SYNDROME;

EID: 0024205642     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0022-510X(88)90203-1     Document Type: Review

References (228)

1. A possible relationship between concentration of microperoxisomes and myelination
2. Cerebro-hepato-renal syndrome
3. Glycogen accumulation in the central nervous system in the cerebro-hepato-renal syndrome
4. Dolichol metabolism and peroxisomes
5. Hyperpipecolic acidaemia: occurrence in an infant with clinical findings of the cerebro-hepato-renal (Zellweger) syndrome
6. Microperoxisomes in the central nervous system of the postnatal rat
7. The cerebro-hepato-renal (Zellweger) syndrome: lamellar lipid profiles in adrenocortical, hepatic mesenchymal, astrocyte cells and increased levels of very long chain fatty acids and phytanic acid in the plasma
8. Neonatal adrenoleukodystrophy
9. Linkage of adrenoleukodystrophy to a polymorphic DNA probe
10. A milder variant of Zellweger syndrome
11. Disorders of neuronal migration
12. A sibship with a mild variant of Zellweger syndrome
13. The cerebro-hepatorenal (Zellweger) syndrome: report of four cases
14. Combined biochemical and morphological study of particulate fractions from rat liver
15. Oxidation of oxalate and polyamines by rat liver peroxisomes
16. New form of adrenoleukodystrophy
17. The renal lesion syndromes of multiple congenital malformations: cerebro-hepato-renal syndrome, Jeune asphyxiating thoracic dystrophy; tuberous sclerosis, Meckel syndrome
18. Long term survival of a patient with the cerebro-hepato-renal (Zellweger) syndrome
19. Peroxisomes and related particles in animal tissues
20. Infantile phytanic acid storage disease: a variant of Refsum's disease?
21. Animal peroxisomes (microbodies), lipid synthesis and Zellweger syndrome
22. A familial syndrome of multiple congenital defects
23. Cerebro-hepato-renal (Zellweger) syndrome and neonatal adrenoleukodystrophy: similarities in phenotype and accumulation of very long chain fatty acids
24. Genetic heterogeneity in the cerebro-hepato-renal (Zellweger) syndrome and other inherited disorders with a generalized impairment of peroxisomal functions: a study using complementation analysis
25. The Zellweger syndrome: subcellular pathology, neuropathology, and the demonstration of pneumocystis carinii pneumonitis in two siblings
26. Dysmorphic syndrome with phytanic acid oxidase deficiency, abnormal very long chain fatty acids, and pipecolic acidaemia: studies in four children
27. Hyperpipecolic acidaemia: clinical and biochemical observations in two male siblings
28. Su di un caso di sindrome cerebrohepato-renale di Zellweger
29. Giant cell transformation
30. Peroxisomal β-oxidation enzyme proteins in adrenoleukodystrophy: distinction between X-linked adrenoleukodystrophy and neonatal adrenoleukodystrophy
31. 3-Hydroxyacyl-CoA epimerase is a peroxisomal enzyme and therefore not involved in mitochondrial fatty acid oxidation
32. Plasma bile acids in patients with peroxisomal dysfunction syndromes: analysis by capillary gas chromatography-mass spectrometry
33. Ocular histopathologic and biochemical studies of the cerebro-hepato-renal syndrome (Zellweger's syndrome) and its relationship to neonatal adrenoleukodystrophy
34. Fatty acid β-oxidation in glyoxysomes from castor bean endosperm
35. The significance of hyperpipecolatemia in Zellweger syndrome
36. Cerebro-hepato-renal syndrome of Zellweger
37. Peroxisomal alanine: glyoxylate aminotransferase deficiency in primary hyperoxaluria type I
38. Deficiency of enzymes catalyzing the biosynthesis of glycerol-ether lipids in Zellweger syndrome: a new category of metabolic disease involving the absence of peroxisomes
39. Peroxisomes (microbodies and related particles)
40. A Golgi study of the brain malformation in Zellweger's cerebro-hepato-renal disease
41. 2α
42. Degradation of unsaturated fatty acids in peroxisomes
43. Atypical phenotype of Refsum's disease: clinical, biochemical, neurophysiological and pathological study
44. Peroxisomal dysfunction in a boy with neurological symptoms and amaurosis (Leber disease): clinical and biochemical findings similar to those observed in the Zellweger syndrome
45. The mechanism of arrest of neuronal migration in the Zellweger malformation: an hypothesis based upon cytoarchitectonic analysis
46. Polypeptide and phospholipid composition of the membrane of rat liver peroxisomes: comparison with endoplasmic reticulum and mitochondrial membranes
47. Tapetoretinal degeneration in the cerebro-hepato-renal (Zellweger's) syndrome
48. Neuronale Migrationsstörung bei cerebro-hepato-renalem Syndrom “Zellweger”
49. Hyperpipecolatemia: a new metabolic disorder associated with neuropathy and hepatomegaly
50. Studies on malformation syndromes of man. XIB. The cerebro-hepato-renal syndrome of Zellweger: comparative pathology
51. Peroxisomal and mitochondrial defects in the cerebro-hepato-renal syndrome
52. Striated adrenocortical cells in cerebro-hepato-renal (Zellweger) syndrome
53. Peroxisomes (microbodies) in cell pathology
54. Peroxisomal defects in neonatal and X-linked adrenoleukodystrophy
55. Pseudo-Zellweger syndrome: deficiencies in several peroxisomal oxidative activities
56. Cerebro-hepato-renal syndrome and thymic aplasia
57. Morphogenesis of peroxisomes in lipid-synthesizing epithelia
58. Identification of a peroxisomal targeting signal at the carboxy terminus of firefly luciferase
59. Cerebro-hepato-renal syndrome of Zellweger: clinical symptoms and relevant laboratory findings in 16 patients
60. Een kind met cerebro-hepato-renaal syndroom van Zellweger
61. A neurophysiological study of children with the cerebro-hepato-renal syndrome of Zellweger
62. Triple therapy of a patient with a peroxisomal disorder
63. Zellweger's variations in expressivity and in defects of bile acid synthesis
64. Diagnosis of Zellweger syndrome by analysis of bile acids and plasmalogens in stored dried blood collected at neonatal screening
65. Cerebro-hepato-renal syndrome of Zellweger
66. Biosynthesis of O-alkylglycerol ether lipids
67. Glycerolipid biosynthesis in peroxisomes via the acyl dihydroxyacetone phosphate pathway
68. Subcellular localization of acylcoenzyme A: dihydroxyacetone phosphate acyltransferase in rat liver peroxisomes (microbodies)
69. Prenatal diagnosis of Zellweger cerebro-hepato-renal syndrome
70. Defects of bile acid synthesis in Zellweger's syndrome
71. Comparison of enzymes of lipid β-oxidation in peroxisomes and mitochondria
72. Lignoceroyl-CoASH ligase: enzyme defect in fatty acid β-oxidation system in X-linked childhood adrenoleukodystrophy
73. Maturation of peroxisomal thiolase protein in rhizomelic chondrodysplasia punctata (RCDP)
74. Cerebro-hepato-renal (Zellweger) syndrome: clinical and biochemical consequences of peroxisomal dysfunction
75. Severe plasmalogen deficiency in tissues of infants without peroxisomes (Zellweger syndrome)
76. Deficiency of plasmalogens in the cerebro-hepato-renal (Zellweger) syndrome
77. Rhizomelic chondrodysplasia punctata: another peroxisomal disorder
78. Peroxisomal abnormalities in rhizomelic chondrodysplasia punctata
79. 14C-leucine into catalase of liver cell fractions in vivo
80. β-oxidation of polyunsaturated fatty acids by rat liver peroxisomes
81. Zellweger syndrome, lenticular opacities indicating carrier status and lens abnormalities characteristic of homozygotes
82. Biochemical abnormalities in rhizomelic chondrodysplasia punctata
83. Oral ether lipid therapy in patients with peroxisomal disorders
84. Peroxisomal enzyme deficiency in the Conradi-Hünermann form of chondrodysplasia punctata
85. Oxidation of spermine and spermidine in rat liver: purification and properties of polyamine oxidase
86. Peroxisomes in nervous tissue
87. The cerebro-hepato-renal syndrome of Zellweger: similarity to and differentiation from the DiGeorge Syndrome
88. Peroxisomal β-oxidation of long-chain fatty acids possessing different extents of unsaturation
89. Translocation of acyl-CoA oxidase into peroxisomes requires ATP hydrolysis but not a membrane potential
90. Cerebro-hepato-renal syndrome of Zellweger
91. 2-enoyl-CoA isomerase activity in rat liver
92. 3-Hydroxy-3-methylglutaryl coenzyme A reductase is present in peroxisomes in normal rat liver cells
93. Increased sensitivity of cerebro-hepato-renal syndrome fibroblasts to antimycin A
94. Hyperpipecolic acidaemia in neonatal adrenoleukodystrophy
95. Neonatal adrenoleukodystrophy: new cases, biochemical studies and differentiation from Zellweger and related peroxisomal polydystrophy syndromes
96. Membrane viscosity is increased in the erythrocytes of patients with adrenoleukodystrophy and adrenomyeloneuropathy
97. Cerebro-hepato-renal syndrome
98. In vitro studies on the oxidation of medium chain dicarboxylic acids in rat liver
99. Ocular manifestations of Conradi and Zellweger syndromes
100. Localization of 3-hydroxy-3-methylglutaryl-Coenzyme A reductase in rat liver peroxisomes
101. l-Pipecolaturia in Zellweger syndrome
102. The role of peroxisomes in mammalian cellular metabolism
103. A fatty acyl-CoA oxidizing system in rat liver peroxisomes: enhancement by clofibrate, a hypolipidemic drug
104. Biogenesis of peroxisomes
105. Zellweger syndrome: biochemical and morphological studies on two patients treated with clofibrate
106. Presence of the peroxisomal 22 kDa integral membrane protein in the liver of a person lacking recognizable peroxisomes (Zellweger syndrome)
107. Inhibition of electron transport and coupled phosphorylation in liver mitochondria by cholenic bile acids and their conjugates
108. Globoid cells, glial nodules, and peculiar fibrillary changes in the cerebro-hepato-renal syndrome of Zellweger
109. The formation of bile acids from cholesterol
110. Aspartoacylase deficiency and N-acetylaspartic aciduria in patients with Canavan disease
111. Liver in the cerebro-hepato-renal syndrome: defective bile acid synthesis and abnormal mitochondria
112. The Zellweger syndrome: editorial comment
113. Neuropathological considerations in cerebro-hepato-renal syndrome (Zellweger syndrome)
114. ACTH receptor defect in adrenoleukodystrophy
115. L-pipecolic catabolism in mammals
116. Very long chain fatty acids in genetic peroxisomal disease fibroblasts: differences between the cerebro-hepato-renal (Zellweger) syndrome and adrenoleukodystrophy variants
117. Peroxisomal disorders: clinical characterization
118. Disappearance of plasmalogens from membranes of animal cells subjected to photosensitized oxidation
119. A new dietary therapy for adrenoleukodystrophy: biochemical and preliminary clinical results in 36 patients
120. The adrenoleukodystrophies
121. Zur Morphologie and Diagnostik des Zellweger Syndroms
122. Mitochondrial myopathy with loosely coupled oxidative phosphorylation in a case of Zellweger syndrome
123. A simple method to diagnose adrenoleukodystrophy using a dried blood spot on filter paper
124. Amino acid metabolism in animal peroxisomes
125. The endoplasmic reticulum in the Golgi zone and its relations to microbodies, Golgi apparatus and autophagic vacuoles in rat liver cells
126. Cerebrotendinous xanthomatosis: a defect in mitochondrial 26-hydroxylation required for normal biosynthesis of cholic acid
127. Absence of hepatic peroxisomes in a case of infantile Refsum's disease
128. The Zellweger syndrome book review and bibliography
129. The Zellweger Syndrome (cerebro-hepato-renal syndrome)
130. Absence of peroxisomes in neonatal onset adrenoleukodystrophy
131. Cerebro-hepato-renal syndrome
132. Cerebro-hepato-renal syndrome of Zellweger
133. Clinical, biochemical and pathological aspects of a “Zellwegerlike” peroxisomal disorder
134. Liver peroxisomes and bile acid formation
135. Licht- und elektronenmikroskopische Leberbefunde beim cerebro-hepato-renalen Syndrome nach Zellweger (peroxisomen-defizienz)
136. Infantile Refsum's disease: biochemical findings suggesting multiple peroxisomal dysfunction
137. Infantile Refsum disease: an inherited peroxisomal disorder; comparison with Zellweger syndrome and neonatal adrenoleukodystrophy
138. A new peroxisomal disorder with enlarged peroxisomes and a specific deficiency of acyl-CoA oxidase (pseudo neonatal adrenoleukodystrophy)
139. Phytanic acid α-oxidation and complementation analysis of classical Refsum and peroxisomal disorders
140. 26 fatty acids in infantile Refsum's disease
141. Identification of 3α, 7α, 12α-trihydroxy-5β-cholestan-26-oic acid, an intermediate in cholic acid synthesis, in the plasma of patients with infantile Refsum's disease
142. Infantile Refsum's disease (phytanic acid storage disease): a variant of Zellweger's syndrome?
143. Patterns of Refsum's disease
144. Accumulation and defective β-oxidation of very long chain fatty acids in Zellweger syndrome, adrenoleukodystrophy and Refsum's disease variants
145. Adreno-leukodystrophy (adreno-testiculo-leuko-myelo-neuropathic complex)
146. Fetal cerebro-hepato-renal (Zellweger) syndrome: dysmorphic, radiologic, biochemical, pathologic findings in four affected fetuses
147. Neuronal lipidosis and neuro-axonal dystrophy in cerebro-hepato-renal (Zellweger) syndrome
148. The cerebrohepato-renal syndrome (CHRS) (Zellweger's syndrome)
149. A syndrome of ocular abnormalities, calcification of the cartilage and failure to thrive
150. Correlation of ultrastructural organization and function in normal and experimentally changed proximal tubule cells of the mouse kidney
151. Adrenoleukodystrophy: oleic acid lowers fibroblast saturated C22-C26 fatty acids
152. Adrenoleukodystrophy: dietary oleic acid lowers hexacosanoate levels
153. Treatment of infantile phytanic acid storage disease: clinical, biochemical and ultrastructural findings in two children treated for 2 years
154. Immediate prenatal diagnosis of Zellweger syndrome by direct measurement of very long chain fatty acids in chorionic villus cells
155. Hepatic peroxisomes are deficient in infantile Refsum disease: a cytochemical study of 4 cases
156. Light microscopic visualization of peroxisomes and plasmalogens in first trimester chorionic villi
157. The cerebro-hepato-renal (Zellweger) syndrome
158. Neonatal adrenoleukodystrophy and cerebro-hepato-renal syndrome: genetic complementation analysis of impaired peroxisomal plasmalogen biosynthesis
159. Microbodies and the problem of mitochondrial regeneration in liver cells
160. Peroxisomal organization in normal and cerebro-hepato-renal (Zellweger) syndrome fibroblasts
161. Peroxisomal membrane ghosts in Zellweger syndrome: aberrant organelle assembly
162. Mitochondrial myopathy of cerebro-hepato-renal (Zellweger) syndrome
163. Adrenoleukodystrophy: a clinical and pathological study of 17 cases
164. β-Oxidation of the carboxyl side chain of prostaglandin E2 in rat liver peroxisomes and mitochondria
165. Alkyldihydroxyacetone phosphate synthase in human skin fibroblasts and its deficiency in Zellweger syndrome
166. The cerebro-hepato-renal (Zellweger) syndrome
167. Plasmalogen biosynthesis in peroxisomal disorders
168. Biosynthesis and maturation of peroxisomal β-oxidation enzymes in fibroblasts in relation to the Zellweger syndrome and infantile Refsum disease
169. Human peroxisomal 3-oxoacyl-coenzyme A thiolase deficiency
170. β-oxidation of unsaturated fatty acids: a revised pathway
171. Deficiency of acyl-CoA: dihydroxyacetone phosphate acyltransferase in patients with Zellweger (cerebro-hepato-renal) syndrome
172. Multiple peroxisomal enzyme deficiencies in rhizomelic chondrodysplasia punctata: comparison with Zellweger syndrome
173. Infantile phytanic acid storage disease: three cases, including ultrastructural studies of the liver
174. Very long chain fatty acid β-oxidation by rat liver mitochondria and peroxisomes
175. Lignoceric acid is oxidized in the peroxisome: implications for the Zellweger cerebro-hepato-renal syndrome and adrenoleukodystrophy
176. The subcellular localization of phytanic acid oxidase in rat liver
177. Phytanic acid oxidase activity in cultured skin fibroblasts
178. Clinical and biochemical heterogeneity in conditions with phytanic acid accumulation
179. Import of the carboxyterminal portion of acyl-CoA oxidase into peroxisomes of Candida tropicalis
180. A syndrome of multiple developmental defects including polycystic kidneys and intrahepatic biliary dysgenesis in 2 siblings
181. The cerebro-hepato-renal syndrome (Zellweger's syndrome)
182. Heterogeneity of chondrodysplasia punctata
183. Cerebro-hepato-renal (Zellweger's) syndrome: ocular involvement
184. Phytanic acid storage disease (Refsum's disease)
185. Disorders related to the metabolism of phytanic acid
186. Deficient activities and proteins of peroxisomal β-oxidation enzymes in infants with Zellweger syndrome
187. Molecular analysis of peroxisomal β-oxidation enzymes in infants with Zellweger syndrome and Zellweger-like syndrome: further heterogeneity of the peroxisomal disorders
188. The topogenic signal of the glycosomal (microbody) phosphoglycerate kinase of Crithidia fasciculata resides in a carboxy-terminal extension
189. Peroxisomal β-oxidation enzyme proteins in the Zellweger syndrome
190. Complementation analysis of peroxisomal diseases by somatic cell fusion
191. A new case of the Zellweger syndrome
192. Hyperpipecolic acidaemia associated with hepatomegaly, mental retardation, optic nerve dysplasia and progressive neurological disease
193. Cholesterol synthesis in rat liver peroxisomes
194. Infantile Refsum's disease: a generalized peroxisomal disorder
195. Etude histologique et ultrastructurale des altérations rétiniennes chez un infant présentant un syndrome de Zellweger
196. Biochemical studies in the cerebro-hepato-renal syndrome of Zellweger: a disturbance in the metabolism of pipecolic acid
197. Biochemical studies in the liver and muscle of patients with Zellweger syndrome
198. Adrenoleukodystrophy: preliminary report of a connatal case
199. Interactions between the ω- and β-oxidations of fatty acids
200. Bile acids in peroxisomal disorders
201. Cerebro-hepato-renal syndrome with parental consanguinity
202. Development of cristalline peroxisomes in methanol-grown cells of the yeast Hansenula polymorpha and its relation to environmental conditions
203. A propos d'un cas de syndrome de Zellweger (syndrome hepato-cerebral-renal)
204. Congenital and familial iron overload
205. Cerebro-hepato-renal syndrome of Zellweger: an inherited disorder of neuronal migration
206. Neuropathology of a peculiar form of cerebro-renal syndrome in a child
207. Activity of peroxisomal enzymes and intracellular distribution of catalase in Zellweger syndrome
208. Deficiency of acyl-CoA: dihydroxyacetone phosphate acyltransferase in thrombocytes of Zellweger patients: a simple postnatal test
209. Genetic relationship between the Zellweger syndrome, infantile Refsum disease and rhizomelic chondrodysplasia punctata
210. Infantile Refsum disease: deficiency of catalase-containing particles (peroxisomes), alkyldihydroxyacetone phosphate synthase and peroxisomal β-oxidation enzyme proteins
211. Peroxisomal very long chain fatty acid β-oxidation in human skin fibroblasts: activity in Zellweger syndrome and other peroxisomal disorders
212. Peroxisomal fatty acid β-oxidation in relation to the accumulation of very long chain fatty acids in cultured skin fibroblasts from patients with Zellweger syndrome and other peroxisomal disorders
213. Studies on the peroxisomal oxidation of palmitate and lignocerate in rat liver
214. Alanine glyoxylate aminotransferase and the urinary excretion of oxalate and glycollate in hyperoxaluria type I and the Zellweger syndrome
215. Age-related accumulation of phytanic acid in plasma from patients with the cerebro-hepato-renal (Zellweger) syndrome
216. Peroxisomal functions in classical Refsum's disease: comparison with the infantile form of Refsum's disease
217. Direct demonstration that the deficient oxidation of very long chain fatty acids in X-linked adrenoleukodystrophy is due to an impaired ability of peroxisomes to activate very long chain fatty acids
218. Peroxisomes and peroxisomal functions in hyperpipecolic acidaemia
219. Identification of l-pipecolic oxidase in human liver and its deficiency in the Zellweger syndrome
220. Ophthalmic manifestations in infantile phytanic acid storage disease
221. Effects of long-chain, saturated fatty acids on membrane microviscosity and adrenocorticotropin responsiveness of human adrenocortical cells in vitro
222. Presence of peroxisomal membrane proteins in liver and fibroblasts from patients with the Zellweger syndrome and related disorders: evidence for the existence of peroxisomal ghosts
223. Roentgenographic features of the cerebro-hepato-renal syndrome of Zellweger
224. Brain phospholipids
225. Chain-shortening of a xenobiotic acyl compound by the peroxisomal β-oxidation system in rat liver
226. Three-dimensional reconstruction of a peroxisome reticulum in regenerating rat liver: evidence of interconnections between heterogeneous segments
227. Immunoelectron microscopy of peroxisomal enzymes: their substructural association and compartmentalization in rat kidney peroxisomes
228. A possible role for plasmalogens in protecting animal cells against photosensitized killing